Home › Asset managers › Compare 2025-2026 › American Century vs Charles Schwab
American Century 2025-2026 · Charles Schwab 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 14,033 | 12,345 | 1,588 | 100 | 88.6% | 88.3% |
| Board proposals | 13,138 | 11,577 | 1,486 | 75 | 88.6% | 88.4% |
| E&S shareholder proposals | 154 | 148 | 6 | 0 | 96.1% | 96.1% |
| Other items | 741 | 620 | 96 | 25 | 86.6% | 85.8% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,561 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Charles Schwab |
|---|---|---|---|---|---|---|
| PRA GROUP, INC. | June 16, 2026 | Approval of an amendment to increase the share authorization under PRA Group, Inc.'s 2022 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
| PRAXIS PRECISION MEDICINES, INC. | June 10, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 6 funds |
| PRECISION BIOSCIENCES, INC. | May 21, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers (commonly referred to as the ''say-on-pay vote''). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| PREMIER, INC. | November 21, 2025 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation proposal"). Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 8 funds |
| PRESTIGE CONSUMER HEALTHCARE INC. | August 5, 2025 | Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| PRIMO BRANDS CORPORATION | April 28, 2026 | Advisory Vote to Approve Executive Compensation. Approval, on an advisory (non-binding) basis, of the compensation of Primo Brands Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| PRIVIA HEALTH GROUP, INC. | May 20, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). Compensation |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| PRO-DEX, INC. | November 20, 2025 | Advisory vote to approve the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| PRO-DEX, INC. | November 20, 2025 | To amend the 2016 Equity Incentive Plan in order to extend its term for an additional ten years. Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| PROCEPT BIOROBOTICS CORPORATION | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| PROG HOLDINGS, INC. | May 6, 2026 | Approval of the amendment to the PROG Holdings, Inc. Amended and Restated 2015 Equity and Incentive Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| PROGRESS SOFTWARE CORPORATION | May 7, 2026 | To approve, on an advisory basis, the compensation of Progress Software Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| PROGYNY, INC. | May 21, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 7 funds |
| PROGYNY, INC. | May 21, 2026 | Election of Directors: Cheryl Scott Director Elections |
Board | For | WITHHOLD 9 funds |
FOR 6 funds |
| PROGYNY, INC. | May 21, 2026 | Election of Directors: Kevin Gordon Director Elections |
Board | For | WITHHOLD 9 funds |
FOR 6 funds |
| PROGYNY, INC. | May 21, 2026 | Election of Directors: Lloyd Dean Director Elections |
Board | For | WITHHOLD 9 funds |
FOR 6 funds |
| PROLOGIS, INC. | April 28, 2026 | Advisory Vote to Approve the Company's Executive Compensation for 2025. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 17 funds |
| PROTAGONIST THERAPEUTICS, INC. | June 17, 2026 | To approve the adoption of the Company's 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| PROTARA THERAPEUTICS, INC. | June 12, 2026 | Approval of an amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| PROTARA THERAPEUTICS, INC. | June 12, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| PROTARA THERAPEUTICS, INC. | June 12, 2026 | Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029 Jesse Shefferman Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| PROTHENA CORPORATION PLC | May 14, 2026 | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| PROVIDENT BANCORP, INC. | September 16, 2025 | The approval, on an advisory (non-binding) basis, of specified compensation that may become payable to the named executive officers of Provident Bancorp, Inc. in connection with the merger. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| PTC THERAPEUTICS, INC. | June 2, 2026 | Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| PUBLIC STORAGE | May 6, 2026 | Election of Trustees: Shankh S. Mitra Director Elections |
Board | For | AGAINST 10 funds |
FOR 18 funds |
| PUBMATIC, INC. | May 29, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| PUMA BIOTECHNOLOGY, INC. | June 11, 2026 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 3 funds |
| PUMA BIOTECHNOLOGY, INC. | June 11, 2026 | Approve an amendment to extend the expiration date until October 4, 2028 of a warrant held by Alan H. Auerbach, as described in the proxy statement. Capital Structure |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| PURE CYCLE CORPORATION | January 14, 2026 | Approval on an advisory basis, of compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| PURECYCLE TECHNOLOGIES, INC. | May 7, 2026 | APPROVE, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| Palo Alto Networks, Inc. | December 9, 2025 | Election of Class II Directors: John M. Donovan Director Elections |
Board | For | FOR 8 funds |
AGAINST 14 funds |
| Personalis, Inc. | May 12, 2026 | Election of Directors: Woodrow A. Myers, Jr., M.D. Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| Planet Labs PBC | July 10, 2025 | To re-elect the following individuals to serve on the board of directors of Planet Labs PBC as Class I directors, until the 2028 annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: William Marshall Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 4 funds |
| Playtika Holding Corp. | June 11, 2026 | Election of Six Directors: Hong Du Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 4 funds |
| Playtika Holding Corp. | June 11, 2026 | Election of Six Directors: Marc Beilinson Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Ponce Financial Group, Inc. | June 11, 2026 | Election of Directors for the term ending in 2029: Steven A. Tsavaris Director Elections |
Board | For | WITHHOLD 5 funds |
FOR 2 funds |
| Prairie Operating Co. | June 3, 2026 | The election of each of the director nominees: Erik Thoresen (Chairman) Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| Prairie Operating Co. | June 3, 2026 | The election of each of the director nominees: Jonathan Gray Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| Prairie Operating Co. | June 3, 2026 | The election of each of the director nominees: Stephen Lee Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| PrimeEnergy Resources Corporation | June 10, 2026 | Election of Directors: H. Gifford Fong Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| QORVO, INC. | August 13, 2025 | To approve the Qorvo, Inc. Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| QORVO, INC. | August 13, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (as disclosed in the proxy statement). Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 13 funds |
| QUALCOMM INCORPORATED | March 17, 2026 | Approval of the Amended and Restated QUALCOMM Incorporated 2023 Long-Term Incentive Plan, including an increase in the share reserve by 24,000,000. Compensation |
Board | For | AGAINST 12 funds |
FOR 13 funds |
| QUALYS, INC. | June 10, 2026 | To approve Qualys, Inc.'s 2012 Equity Incentive Plan, as amended and restated. Compensation |
Board | For | AGAINST 9 funds |
FOR 9 funds |
| QUANEX BUILDING PRODUCTS CORP | February 26, 2026 | To approve an advisory resolution approving the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 8 funds |
| QUANTERIX CORPORATION | September 29, 2025 | Approve, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| QUANTUMSCAPE CORPORATION | June 3, 2026 | To approve, on a non-binding advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 6 funds |
| QUICKLOGIC CORPORATION | May 7, 2026 | To approve, on a non-binding advisory basis, the compensation of QuickLogic's named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 2 funds |
| QXO, INC. | May 5, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| RANPAK HOLDINGS CORP | May 21, 2026 | Company Proposal - Approval of a non-binding advisory resolution approving the compensation of named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| RAYMOND JAMES FINANCIAL, INC. | February 19, 2026 | To approve the Amended and Restated 2012 Stock Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 13 funds |
| RAYONIER ADVANCED MATERIALS INC | May 13, 2026 | Approval of the French Sub-Plan to be Implemented Under the Rayonier Advanced Materials Inc. 2023 Incentive Stock Plan, as Amended and Restated. Compensation |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| RECURSION PHARMACEUTICALS, INC. | June 17, 2026 | Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| RED ROCK RESORTS, INC. | June 4, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| REGENXBIO INC. | May 29, 2026 | Advisory vote on the compensation paid to the Company's executive employees. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| REGENXBIO INC. | May 29, 2026 | To approve a stock option exchange for our executive employees. Compensation |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| REGENXBIO INC. | May 29, 2026 | To approve a stock option exchange for our non-executive employees. Compensation |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| REGIONAL MANAGEMENT CORP. | May 14, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 7 funds |
| REGIONAL MANAGEMENT CORP. | May 14, 2026 | Re-approval of the Regional Management Corp. 2024 Long-Term Incentive Plan (as amended and restated effective as of May 14, 2026). Compensation |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| RELAY THERAPEUTICS, INC. | June 9, 2026 | To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal; Douglas S. Ingram Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REMITLY GLOBAL, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 5 funds |
| RENAISSANCERE HOLDINGS LTD. | May 5, 2026 | To approve the RenaissanceRe Holdings Ltd. 2026 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 9 funds |
| REPLIMUNE GROUP INC | September 3, 2025 | To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Alejandro M. Sanchez Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Andrew Trager-Kusman Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Ernest W. Marshall, Jr. Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Heather V. Howell Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Jennifer N. Green Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Logan M. Pichel Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Steven E. Trager Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Timothy S. Huval Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Vidya Ravichandran Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: W. Kennett Oyler, III Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| REPUBLIC BANCORP, INC. | April 23, 2026 | Election of Directors: Yoania Cannon Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 4 funds |
| RESMED INC. | November 19, 2025 | Approve the amendment and restatement of our 2009 Incentive Award Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 15 funds |
| RESOURCES CONNECTION, INC. | October 16, 2025 | The approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 7 funds |
| REV GROUP, INC. | January 28, 2026 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to REV's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement (the ''REV advisory compensation proposal''). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 8 funds |
| REVOLUTION MEDICINES, INC. | June 18, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 9 funds |
| REVOLVE GROUP, INC. | June 5, 2026 | The approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| REXFORD INDUSTRIAL REALTY, INC. | May 19, 2026 | The advisory resolution to approve the Company's named executive officer compensation for the fiscal year ended December 31, 2025, as decribed in the Rexford Industrial Realty, Inc. Proxy Statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 15 funds |
| REXFORD INDUSTRIAL REALTY, INC. | May 19, 2026 | The approval of the Fourth Amended and Restated Rexford Industrial Realty, Inc. and Rexford Industrial Realty, L.P. 2013 Incentive Award Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 14 funds |
| RGC RESOURCES, INC. | January 26, 2026 | A non-binding shareholder advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| RH | June 18, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 11 funds |
| RHYTHM PHARMACEUTICALS, INC. | June 24, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 9 funds |
| RICHARDSON ELECTRONICS, LTD. | October 7, 2025 | To approve an amendment to the Amended and Restated 2011 Long-Term Incentive Plan to increase the number of shares available for issuance under the Plan. Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| RICHARDSON ELECTRONICS, LTD. | October 7, 2025 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| RIGEL PHARMACEUTICALS, INC. | May 14, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| RIGEL PHARMACEUTICALS, INC. | May 14, 2026 | To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
AGAINST 5 funds |
| RILEY EXPLORATION PERMIAN, INC. | May 12, 2026 | Approval of the amendment and restatement of the Riley Exploration Permian, Inc. Amended and Restated 2021 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| RIVERVIEW BANCORP, INC. | August 28, 2025 | Advisory (non-binding) vote to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| ROCKWELL AUTOMATION, INC. | February 10, 2026 | To approve the Rockwell Automation, Inc. 2026 Long-Term Incentives Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 16 funds |
| ROCKWELL AUTOMATION, INC. | February 10, 2026 | To approve, on an advisory basis, the compensation of the Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 18 funds |
| ROOT, INC. | June 3, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 5 funds |
| ROSS STORES, INC. | May 20, 2026 | To approve the Ross Stores, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 14 funds |
| ROYALTY PHARMA PLC | June 4, 2026 | A non-binding advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 13 funds |
| ROYALTY PHARMA PLC | June 4, 2026 | Approve on a non-binding advisory basis our U.K. directors' remuneration report for the fiscal year ended December 31, 2025. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| RXO, Inc. | May 12, 2026 | Election of Directors: Thomas Szlosek Director Elections |
Board | For | FOR 4 funds |
AGAINST 7 funds |
| RXSIGHT, INC. | June 16, 2026 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2025 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 5 funds |
| RYAN SPECIALTY HOLDINGS, INC. | April 28, 2026 | To approve, by a non-binding advisory vote, the compensation of our named executive officers (i.e., "say-on-pay proposal"). Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| RYERSON HOLDING CORPORATION | April 30, 2026 | The approval of the Third Amended and Restated Ryerson Holding Corporation 2014 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 7 funds |
← Previous Page 11 of 16 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.